Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia Article

Ha, Alison W, Sudhadevi, Tara, Ebenezer, David L et al. (2020). Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia . AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 319(3), L497-L512. 10.1152/ajplung.00169.2020

Open Access

cited authors

  • Ha, Alison W; Sudhadevi, Tara; Ebenezer, David L; Fu, Panfeng; Berdyshev, Evgeny; Ackerman, Steven J; Natarajan, Viswanathan; Harijith, Anantha

sustainable development goals

authors

publication date

  • September 1, 2020

webpage

published in

keywords

  • 1-PHOSPHATE
  • CELLS
  • CT
  • EPITHELIAL-MESENCHYMAL INTERACTIONS
  • GENERATION
  • HYPERRESPONSIVENESS
  • INFLAMMATION
  • LUNG-FUNCTION
  • Life Sciences & Biomedicine
  • PF543
  • PRETERM INFANTS
  • Physiology
  • Respiratory System
  • SPHINGOSINE-1-PHOSPHATE
  • Science & Technology
  • airway remodeling
  • bronchopulmonary dysplasia
  • mitochondrial ROS
  • sphingosine kinase 1

Digital Object Identifier (DOI)

publisher

  • AMER PHYSIOLOGICAL SOC

start page

  • L497

end page

  • L512

volume

  • 319

issue

  • 3